Metabolic Tumor Volume Measured by (18)F-FDG PET/CT is Associated with the Survival of Unresectable Hepatocellular Carcinoma Treated with PD-1/PD-L1 Inhibitors Plus Molecular Targeted Agents

PURPOSE: The combination of PD-1/PD-L1 inhibitors and molecular targeted agents showed promising efficacy for unresectable hepatocellular carcinoma (uHCC). This study aimed to investigate the prognostic value of metabolic parameters from (18)F-fluorodeoxyglucose positron emission tomography-computed...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xuezhu, Yang, Xu, Wang, Jingnan, Dong, Chengyan, Ding, Jie, Wu, Meiqi, Wang, Yanyu, Ding, Haiyan, Zhang, Hui, Sang, Xinting, Zhao, Haitao, Huo, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094465/
https://www.ncbi.nlm.nih.gov/pubmed/37063093
http://dx.doi.org/10.2147/JHC.S401647

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094465/
https://www.ncbi.nlm.nih.gov/pubmed/37063093
http://dx.doi.org/10.2147/JHC.S401647

Ejemplares similares